247 related articles for article (PubMed ID: 37556531)
41. The role of the histone H2A ubiquitinase Sce in Polycomb repression.
Gutiérrez L; Oktaba K; Scheuermann JC; Gambetta MC; Ly-Hartig N; Müller J
Development; 2012 Jan; 139(1):117-27. PubMed ID: 22096074
[TBL] [Abstract][Full Text] [Related]
42. Role of histone variants H2BC1 and H2AZ.2 in H2AK119ub nucleosome organization and Polycomb gene silencing.
Shen X; Chen C; Wang Y; Zheng W; Zheng J; Jones AE; Zhu B; Zhang H; Lyons C; Rijal A; Moley JA; Cao G; Liu K; Winn R; Dickinson A; Zhang K; Wang H
bioRxiv; 2024 Jan; ():. PubMed ID: 38293106
[TBL] [Abstract][Full Text] [Related]
43. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.
Abdel-Wahab O; Dey A
Leukemia; 2013 Jan; 27(1):10-5. PubMed ID: 23147254
[TBL] [Abstract][Full Text] [Related]
44. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
[TBL] [Abstract][Full Text] [Related]
45. Deregulation of tumor suppressive ASXL1-PTEN/AKT axis in myeloid malignancies.
Cao L; Xia X; Kong Y; Jia F; Yuan B; Li R; Li Q; Wang Y; Cui M; Dai Z; Zheng H; Christensen J; Zhou Y; Wu X
J Mol Cell Biol; 2020 Sep; 12(9):688-699. PubMed ID: 32236560
[TBL] [Abstract][Full Text] [Related]
46. Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.
Kolluri KK; Alifrangis C; Kumar N; Ishii Y; Price S; Michaut M; Williams S; Barthorpe S; Lightfoot H; Busacca S; Sharkey A; Yuan Z; Sage EK; Vallath S; Le Quesne J; Tice DA; Alrifai D; von Karstedt S; Montinaro A; Guppy N; Waller DA; Nakas A; Good R; Holmes A; Walczak H; Fennell DA; Garnett M; Iorio F; Wessels L; McDermott U; Janes SM
Elife; 2018 Jan; 7():. PubMed ID: 29345617
[TBL] [Abstract][Full Text] [Related]
47. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
Asada S; Kitamura T
Int J Hematol; 2019 Aug; 110(2):179-186. PubMed ID: 30515738
[TBL] [Abstract][Full Text] [Related]
48. Proteomic analysis identifies novel binding partners of BAP1.
Baas R; J van der Wal F; Bleijerveld OB; van Attikum H; Sixma TK
PLoS One; 2021; 16(9):e0257688. PubMed ID: 34591877
[TBL] [Abstract][Full Text] [Related]
49. Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.
Arenzana TL; Lianoglou S; Seki A; Eidenschenk C; Cheung T; Seshasayee D; Hagenbeek T; Sambandam A; Noubade R; Peng I; Lesch J; DeVoss J; Wu X; Lee WP; Caplazi P; Webster J; Liu J; Pham VC; Arnott D; Lill JR; Modrusan Z; Dey A; Rutz S
Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29678836
[TBL] [Abstract][Full Text] [Related]
50. Roles and mechanisms of BAP1 deubiquitinase in tumor suppression.
Masclef L; Ahmed O; Estavoyer B; Larrivée B; Labrecque N; Nijnik A; Affar EB
Cell Death Differ; 2021 Feb; 28(2):606-625. PubMed ID: 33462414
[TBL] [Abstract][Full Text] [Related]
51. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.
Abdel-Wahab O; Adli M; LaFave LM; Gao J; Hricik T; Shih AH; Pandey S; Patel JP; Chung YR; Koche R; Perna F; Zhao X; Taylor JE; Park CY; Carroll M; Melnick A; Nimer SD; Jaffe JD; Aifantis I; Bernstein BE; Levine RL
Cancer Cell; 2012 Aug; 22(2):180-93. PubMed ID: 22897849
[TBL] [Abstract][Full Text] [Related]
52. The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.
Ji Z; Mohammed H; Webber A; Ridsdale J; Han N; Carroll JS; Sharrocks AD
Nucleic Acids Res; 2014 Jun; 42(10):6232-42. PubMed ID: 24748658
[TBL] [Abstract][Full Text] [Related]
53. Modulation of Schwann cell homeostasis by the BAP1 deubiquitinase.
Duong P; Ramesh R; Schneider A; Won S; Cooper AJ; Svaren J
Glia; 2023 Jun; 71(6):1466-1480. PubMed ID: 36790040
[TBL] [Abstract][Full Text] [Related]
54. The Functions and Mechanisms of PR-DUB in Malignancy.
Cao L; Li R; Wu X
Front Mol Biosci; 2021; 8():657150. PubMed ID: 33796551
[TBL] [Abstract][Full Text] [Related]
55. Histone H2A monoubiquitination and Polycomb repression: the missing pieces of the puzzle.
Scheuermann JC; Gutiérrez L; Müller J
Fly (Austin); 2012; 6(3):162-8. PubMed ID: 22836728
[TBL] [Abstract][Full Text] [Related]
56. BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability.
Lee SA; Lee D; Kang M; Kim S; Kwon SJ; Lee HS; Seo HR; Kaushal P; Lee NS; Kim H; Lee C; Kwon J
Cell Death Differ; 2022 Dec; 29(12):2381-2398. PubMed ID: 35637285
[TBL] [Abstract][Full Text] [Related]
57. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.
Wang L; Zhao Z; Ozark PA; Fantini D; Marshall SA; Rendleman EJ; Cozzolino KA; Louis N; He X; Morgan MA; Takahashi YH; Collings CK; Smith ER; Ntziachristos P; Savas JN; Zou L; Hashizume R; Meeks JJ; Shilatifard A
Nat Med; 2018 Jun; 24(6):758-769. PubMed ID: 29785026
[TBL] [Abstract][Full Text] [Related]
58. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1.
Zhang Y; Koppula P; Gan B
Cell Cycle; 2019 Apr; 18(8):773-783. PubMed ID: 30907299
[TBL] [Abstract][Full Text] [Related]
59. Polycomb group proteins in the DNA damage response: a link between radiation resistance and "stemness".
Gieni RS; Ismail IH; Campbell S; Hendzel MJ
Cell Cycle; 2011 Mar; 10(6):883-94. PubMed ID: 21346409
[TBL] [Abstract][Full Text] [Related]
60. Germline mutations in BAP1 impair its function in DNA double-strand break repair.
Ismail IH; Davidson R; Gagné JP; Xu ZZ; Poirier GG; Hendzel MJ
Cancer Res; 2014 Aug; 74(16):4282-94. PubMed ID: 24894717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
